Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
Combination Chemotherapy in Treating Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated
- Status
- COMPLETED
- Phase
- PHASE3
Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan
- Status
- COMPLETED
- Phase
- PHASE2
Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1